MARSHALL WACE, LLP - CELLULAR BIOMEDICINE GROUP I ownership

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CELLULAR BIOMEDICINE GROUP I
ValueSharesWeighting
Q4 2020$392,000
-68.7%
21,315
-68.8%
0.00%
-75.0%
Q3 2020$1,254,00068,3720.01%
Other shareholders

There were no reported owners of CELLULAR BIOMEDICINE GROUP I in Q1 2021.

NameSharesValueWeighting ↓
View complete list of CELLULAR BIOMEDICINE GROUP I shareholders